targeted therapy
Coverage of targeted therapy in the Nexus archive.
- First-of-kind Guillain-Barré drug switches off part of immune system
A treatment that inhibits the immune system component responsible for Guillain-Barré syndrome could become the first targeted therapy approved for the autoimmune condition.
- A 44-year-old mom felt out of breath while talking. It turns out she had stage 4 lung cancer, despite never smoking.
A 44-year-old mom, Summer Farmen, was diagnosed with stage 4 alk-positive lung cancer despite never smoking. She became an advocate for research and education on the disease and has survived for six years using targeted therapy medications.
- Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study
A Hong Kong co-led global study found that the third-generation targeted therapy lorlatinib kept over half of advanced lung cancer patients alive without disease progression for at least seven years, potentially transforming the disease into a chronic condition. The research was conducted by the Chinese University of Hong Kong.
- Pancreatic cancer: Dr. Pudlarz praises 'new generation targeted therapy' that inhibits gene mutation
Dr. Thomas Pudlarz, a Medical Oncologist at the Gustave-Roussy Institute, highlights a new experimental targeted therapy for pancreatic cancer as a significant advancement. Pancreatic cancer remains a major challenge in oncology, but this therapy represents one of the first improvements in many years.